PMID: 11606852Oct 19, 2001Paper

Vigorous achalasia: original description requires minor change

Journal of Clinical Gastroenterology
L Camacho-LobatoD O Castell

Abstract

Vigorous achalasia was described in 1957 as a subset of achalasia with a higher contraction amplitude (>37 mm Hg), minimal esophageal dilatation, prominent tertiary contractions, and higher incidence of chest pain. Ascertain the existence of a distinct achalasia group based on manometric, radiographic, and clinical grounds. The records of 209 idiopathic achalasia patients seen over a 9-year interval were reviewed for duration and frequency of dysphagia, chest pain, heartburn, weight loss, and nocturnal symptoms, as well as for treatment outcome. Manometric tracings were reanalyzed for lower esophageal sphincter pressure (LESP), LES residual pressure, distal esophageal contraction amplitude, and presence of repetitive waves. Patients were subsequently divided into classic (amplitude < or =37 mm Hg) and vigorous (amplitude >37 mm Hg) achalasia groups. Esophagrams were reassessed blindly for esophageal diameter both in the upright and recumbent positions and presence of lumen-occlusive tertiary contractions. One hundred forty-four classic and 65 vigorous achalasia patients were identified. These groups were similar in age and gender, as well as duration of symptoms. Chest pain was equally prevalent in both groups. Lower esophageal...Continue Reading

References

Dec 1, 1992·Gastroenterology·R W Goodgame, D Y Graham
Mar 1, 1991·Digestive Diseases and Sciences·J R TodorczukR E Clouse
Dec 15, 1987·Hospital Practice·R W McCallum
Jan 1, 1988·Digestion·C S RobertsonM Atkinson
Oct 1, 1967·Diseases of the Chest·D R SandersonA M Olsen
Feb 12, 1998·Gut·M GonzálezJ R Malagelada
Feb 1, 1957·American Journal of Surgery·B CREAMERA M OLSEN

❮ Previous
Next ❯

Citations

Oct 7, 2005·Journal of Clinical Gastroenterology·Roberto Oliveira Dantas, Lilian Rose Otoboni Aprile
Jul 23, 2011·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·R Fass, S R Achem
Oct 15, 2013·Annals of the New York Academy of Sciences·Anne Lund KrarupSami R Achem
Oct 20, 2011·The American Journal of Gastroenterology·Jose C HernandezMichael D Crowell
Jul 14, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·V KushnirC P Gyawali
Jun 23, 2011·Journal of Pediatric Gastroenterology and Nutrition·Claudio Morera, Samuel Nurko
Oct 28, 2016·World Journal of Gastroenterology : WJG·Amar TebaibiaNadia Oumnia
Oct 13, 2006·Current Opinion in Gastroenterology·Chandra Prakash, Ray E Clouse
May 16, 2006·Alimentary Pharmacology & Therapeutics·G BassottiV Annese
Sep 18, 2009·Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract·Garrett R RollGuilherme M Campos
Sep 27, 2007·Orphanet Journal of Rare Diseases·Farnoosh Farrokhi, Michael F Vaezi
Jun 25, 2005·Arquivos De Gastroenterologia·Roberto Oliveira Dantas, Lilian Rose Otoboni Aprile
Jul 28, 2010·Journal of Gastroenterology and Hepatology·Kee Wook JungJin-Ho Kim
Oct 7, 2017·Esophagus : Official Journal of the Japan Esophageal Society·UNKNOWN Japan Esophageal Society
Dec 11, 2002·Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus·R O Dantas
Jul 23, 2013·Journal of Neurogastroenterology and Motility·Kwangwon RheeSang In Lee
Jan 29, 2008·Journal of Clinical Gastroenterology·Amit AgrawalDonald O Castell

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Journal of Urology
Samih Al-Hayek, Paul Abrams
Journal of the Formosan Medical Association = Taiwan Yi Zhi
Ming-Chih YuChun-Nin Lee
British Journal of Pharmacology and Chemotherapy
K B JENSEN
© 2021 Meta ULC. All rights reserved